AN3661
AN3661, a potent antimalarial lead compound, targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue subunit 3 (PfCPSF3) . AN3661 inhibits Plasmodium falciparum laboratory-adapted strains (mean IC50=32 nM), Ugandan field isolates (mean ex vivo IC50=64 nM), and murine P. berghei and P. falciparum infections[1].
Product Specifications
CAS Number
1268335-33-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/an3661.html
Concentration
10mM
Purity
99.89
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(O)CCC1=C(B(O)OC2)C2=CC=C1
Molecular Formula
C10H11BO4
Molecular Weight
206.00
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Plasmodium
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Arp2 (ACTR2) (NM_005722) Human Over-expression Lysate
GM CSF Receptor alpha (CSF2RA) (NM_172247) Human Over-expression Lysate
C6orf64 (SAYSD1) (NM_018322) Human Recombinant Protein
